Vogelstein R Jacob
Insider CIK 2154030 · IAM Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 742,546 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 1,458,290 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 122,684 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 731,187 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 1,141,878 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion | 2026-10-16 | 2026-10-19 | 742,546 | — | — | 742,546 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion | 2026-10-16 | 2026-10-19 | 1,458,290 | — | — | 1,458,290 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion | 2026-10-16 | 2026-10-19 | 1,995,749 | — | — | 1,995,749 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | A Award deriv | 2026-10-14 | 2026-10-16 | 20,300 | — | $0 | 20,300 | SEC↗ |